Big Pharma's Q2 2010 Earnings Report

by Maureen Martino and Erica Teichert

Need a Big Pharma financial fix? Look no further. FiercePharma is launching a new feature to help you keep track of drugmakers' quarterly results. We've compiled earnings reports from the top 10 companies in pharma, as ranked by 2009 revenues. Each profile includes earnings summaries, quick factoids on the numbers, and links to company news. Check out the list below, or click through any of our reports on these companies.

1. Johnson & Johnson's Q2 earnings
2. Pfizer's Q2 earnings
3. Roche's Q2 earnings
4. GlaxoSmithKline's Q2 earnings
5. Novartis' Q2 earnings
6. Sanofi-Aventis's Q2 earnings
7. AstraZeneca's Q2 earnings
8. Abbott Labs' Q2 earnings
9. Merck's Q2 earnings 
10. Bayer Healthcare's Q2 earnings

Read more on

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.